Stay updated with breaking news from Jon Yu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Data published in the Journal of Pharmaceutical Sciences support further development of caffeine as a viscosity reducing agent for subcutaneous formulations of monoclonal antibodies WOBURN, Mass.,... -Today at 08:01 am- MarketScreener
Data published in the Journal of Pharmaceutical Sciences support further development of caffeine as a viscosity reducing agent for subcutaneous formulations of monoclonal antibodies
Phase 2a data published in The Lancet’s eBioMedicinesupports further development of UB-311
CAPE CANAVERAL, Fla., Aug. 09, 2023 -- Vaxxinity, Inc. ; class='js-l-obf link link--blue'
WOBURN, Mass., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. ( Nasdaq: CMRA ), a life sciences company developing a new generation of biologic medicines to improve